Mitigation of Indomethacin-Induced Gastric Ulcer in Rats by 2,3-Dichloro-6-(trifluoromethoxy) quinoxaline: Modulation of Inflammatory Mechanisms
Journal of Contemporary Medical Sciences · 30.08.2024 · 10 (4)
DOI: 10.22317/jcms.v10i4.1582 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Contemporary Medical Sciences, online erschienen am 30.08.2024. Verfasst von Karem Ibrahem und 15 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To investigate the gastroprotective influence of 2,3-Dichloro-6-(trifluoromethoxy) quinoxaline in a rat model of indomethacininducedgastric ulcers.
Methods
Thirty male Wistar rats were randomly divided into five groups (n = 6) as follows: Group 1 (control), Group 2 (indomethacin only, 30 mg/kg), Group 3 (indomethacin and 2,3-Dichloro-6-(trifluoromethoxy) quinoxaline, 30 mg/kg), Group 4 (indomethacin with 2,3-Dichloro-6-(trifluoromethoxy) quinoxaline, 60 mg/kg), and Group 5 (indomethacin with esomeprazole, 30 mg/kg). The efficacy of 2,3-Dichloro-6-(trifluoromethoxy) quinoxaline in mitigating gastric ulcers induced by indomethacin in rats was evaluated based on gastric morphology, histopathology, and inflammatory biomarkers.
Results
Indomethacin-induced stomach ulcers resulted in epithelial damage and blood streaks on the gastric mucosa. However, treatmentwith indomethacin and 2,3-Dichloro-6-(trifluoromethoxy) quinoxaline (60 mg/kg) significantly (P < 0.05) reduced ulcers compared to the indomethacin-only group. Inflammatory cells were observed in the indomethacin group, while the 60 mg/kg 2,3-Dichloro-6- (trifluoromethoxy) quinoxaline-treated group exhibited the restoration of normal epithelial tissue and minimal inflammatory cells, similar to the control and esomeprazole-treated groups. Furthermore, 2,3-Dichloro-6-(trifluoromethoxy) quinoxaline significantly decreased inflammatory biomarkers (TNF-α, IL-6, INF-γ, and IL-β1) and increased gastroprotective mediator levels (PGE2 and mucin), both with P-values below 0.05, in contrast to the effects of indomethacin.
Conclusion
This study provides clinical evidence highlighting the gastroprotective properties of 2,3-Dichloro-6-(trifluoromethoxy) quinoxaline. Its initial application reveals, for the first time, its efficacy in treating gastric ulcers induced by indomethacin. However, further tests are warranted to validate these findings.
Zitieren
APA
Ibrahem, K., Daghistani, H., Almoghrabi, Y., Shamrani, T., Jawi, M., Bazuhair, M., Labban, S., Mokhtar, J., Niyazi, H., Niyazi, H., Helmi, N., AbdulMajed, H., Juma, N., Daffa, N., Al-Rabia, M., & Elfadi, A. (2024). Mitigation of Indomethacin-Induced Gastric Ulcer in Rats by 2,3-Dichloro-6-(trifluoromethoxy) quinoxaline: Modulation of Inflammatory Mechanisms. Journal of Contemporary Medical Sciences, 10(4). https://doi.org/10.22317/jcms.v10i4.1582
Vancouver
Ibrahem K, Daghistani H, Almoghrabi Y, Shamrani T, Jawi M, Bazuhair M, et al. Mitigation of Indomethacin-Induced Gastric Ulcer in Rats by 2,3-Dichloro-6-(trifluoromethoxy) quinoxaline: Modulation of Inflammatory Mechanisms. Journal of Contemporary Medical Sciences. 2024;10(4). doi:10.22317/jcms.v10i4.1582
BibTeX
@article{Ibrahem2024,
author = {Ibrahem, Karem and Daghistani, Hussam and Almoghrabi, Yousef and Shamrani, Taghreed and Jawi, Motasim and Bazuhair, Mohammed and Labban, Samah and Mokhtar, Jawahir and Niyazi, Hanouf and Niyazi, Hatoon and Helmi, Noof and AbdulMajed, Hind and Juma, Noha and Daffa, Noura and Al-Rabia, Mohammed and Elfadi, Abdelbagi},
title = {Mitigation of Indomethacin-Induced Gastric Ulcer in Rats by 2,3-Dichloro-6-(trifluoromethoxy) quinoxaline: Modulation of Inflammatory Mechanisms},
journal = {Journal of Contemporary Medical Sciences},
year = {2024},
volume = {10},
number = {4},
doi = {10.22317/jcms.v10i4.1582}
}
EUVIMED